Table: Jcr Pharmaceuticals -2022/23 parent results

JCR Pharmaceuticals

11/05/2023 08:00

May 11 (Reuters)- 
          Jcr Pharmaceuticals Co., Ltd. 
          PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                   Year ended      Year ended       Year to     NEXT     
                Mar 31, 2023    Mar 31, 2022   Mar 31, 2024     YEAR     
                   LATEST         YEAR-AGO        COMPANY      COMPANY   
                   RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales             34.34           51.08                                
                 (-32.8 pct)     (+69.8 pct)                             
  Operating          5.10           20.14                                
                 (-74.7 pct)    (+133.0 pct)                             
  Recurring          5.28           20.43                                
                 (-74.1 pct)    (+137.7 pct)                             
  Net                3.69           14.45                                
                 (-74.5 pct)    (+104.0 pct)                             
  EPS             29.67 yen      116.77 yen                              
  EPS Diluted     29.54 yen      116.31 yen                              
  Ann Div         20.00 yen       22.00 yen      20.00 yen               
  -Q2 Div         10.00 yen       10.00 yen      10.00 yen               
  -Q4 Div         10.00 yen       12.00 yen      10.00 yen               
  
  NOTE - Jcr Pharmaceuticals Co., Ltd.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4552.T